Reverse Drilling Technique in Improving Outcomes After Arthroscopic Anterior Cruciate Ligament Reconstruction
Condition(s) studied
Investigational drug(s) / intervention(s)
Reverse drilling technique: A standard hamstring autograft procedure was performed using reverse drilling technique to prepare bone tunnel.
Traditional extraction drilling: A standard hamstring autograft procedure was performed using traditional extraction drilling to prepare bone tunnel.
Study summary
Anterior cruciate ligament (ACL) injuries and bone tunnel enlargement (BTE) after ACL reconstruction (ACLR) remain frequent issues. Bone dust (BD) produced by tunnel preparation with osteogenic ability and reverse drilling (RD), an easy compaction technique, make it accessible to enhance tendon-bone healing in ACLR. We hyposize that RD and BD synergistically improve outcomes after arthroscopic ACLR by improving peritunnel bone and preventing BTE.
Eligibility
Primary outcome measure(s)
- IKDC Subjective Score — Patients will be followed up regularly at 3, 6, 9, 12, and 24 months after surgery.
This table consists of knee joint assessment (10 items) and knee ligament examination (8 items), which includes joint pain, exercise level, and daily activity ability, with a total score of 0-100 points. - Bone tunnel enlargement — Patients will be followed up regularly at 3, 6, 9, 12, and 24 months after surgery.
Measurement of bone tunnel enlargement through postoperative image
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| The First People's Hospital of Huzhou | Huzhou | Zhejiang | |
| Lishui Municipal Central Hospital | Lishui | Zhejiang | |
| Jiande First People's Hospital | Meicheng | Zhejiang | |
| Ningbo Medical Center Lihuili Hospital | Ningbo | Zhejiang | |
| Shaoxing Traditional Chinese Medicine Hospital | Shaoxing | Zhejiang | |
| Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University | Taizhou | Zhejiang |
More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05994872 on ClinicalTrials.gov ↗ ← All trials in China